The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Cleveland Biolabs Inc

Nasdaq: CBLI
Last

(U.S.) $3.28

Today's change+0.05 +1.55%
Updated September 22 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Cleveland Biolabs Inc

Nasdaq: CBLI
Last

(U.S.) $3.28

Today's change+0.05 +1.55%
Updated September 22 4:00 PM -4GMT. Delayed by at least 15 minutes.

Cleveland Biolabs Inc up sharply

Cleveland Biolabs Inc closed up sharply Friday, rallying (U.S.)$0.05 or 1.55% to (U.S.)$3.28. Over the last five days, shares have gained 13.10% and 130.99% year to date. Shares have outperformed the S&P 500 by 88.80% during the last year.

Key company metrics

  • Open(U.S.) $3.20
  • Previous close(U.S.) $3.23
  • High(U.S.) $3.28
  • Low(U.S.) $3.18
  • Bid / Ask(U.S.) $0.00 / (U.S.) $5.50
  • YTD % change+130.99%
  • Volume22,727
  • Average volume (10-day)32,748
  • Average volume (1-month)45,525
  • Average volume (3-month)84,398
  • 52-week range(U.S.) $1.22 to (U.S.) $5.55
  • Beta0.02
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.66
Updated September 22 4:00 PM -4GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue0111
Total other revenue--------
Total revenue0111
Gross profit--------
Total cost of revenue--------
Total operating expense2232
Selling / general / administrative1111
Research & development1121
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-2-2-2-1
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-6-2-11
Income after tax-6-2-11
Income tax, total--------
Net income-6-2-11
Total adjustments to net income--------
Net income before extra. items-6-2-11
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-6-2-11
Inc. avail. to common incl. extra. items-6-2-11
Diluted net income-6-2-11
Dilution adjustment--------
Diluted weighted average shares11111111
Diluted EPS excluding extraordinary itemsvalue per share-0.50-0.15-0.110.10
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.50-0.15-0.110.10